These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 38909325
1. WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells. Iaiza A, Mazzanti G, Goeman F, Cesaro B, Cortile C, Corleone G, Tito C, Liccardo F, De Angelis L, Petrozza V, Masciarelli S, Blandino G, Fanciulli M, Fatica A, Fontemaggi G, Fazi F. Cell Mol Life Sci; 2024 Jun 23; 81(1):276. PubMed ID: 38909325 [Abstract] [Full Text] [Related]
2. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA. Naren D, Yan T, Gong Y, Huang J, Zhang D, Sang L, Zheng X, Li Y. J Cancer Res Clin Oncol; 2021 Jan 23; 147(1):33-47. PubMed ID: 32880751 [Abstract] [Full Text] [Related]
3. Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress. Costa RGA, Oliveira MS, Rodrigues ACBDC, Silva SLR, Dias IRSB, Soares MBP, de Faro Valverde L, Gurgel Rocha CA, Dias RB, Bezerra DP. J Cell Mol Med; 2024 Apr 23; 28(8):e18333. PubMed ID: 38652192 [Abstract] [Full Text] [Related]
4. WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA. Wang J, Zhang J, Ma Y, Zeng Y, Lu C, Yang F, Jiang N, Zhang X, Wang Y, Xu Y, Hou H, Jiang S, Zhuang S. Aging (Albany NY); 2021 Mar 26; 13(8):11135-11149. PubMed ID: 33819187 [Abstract] [Full Text] [Related]
5. Expression profiling of N6-methyladenosine modified circRNAs in acute myeloid leukemia. Issah MA, Wu D, Zhang F, Zheng W, Liu Y, Chen R, Lai G, Shen J. Biochem Biophys Res Commun; 2022 Apr 23; 601():137-145. PubMed ID: 35247767 [Abstract] [Full Text] [Related]
6. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. Ma H, Shen L, Yang H, Gong H, Du X, Li J. IUBMB Life; 2021 Jan 23; 73(1):108-117. PubMed ID: 33205540 [Abstract] [Full Text] [Related]
7. Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer. Wei W, Sun J, Zhang H, Xiao X, Huang C, Wang L, Zhong H, Jiang Y, Zhang X, Jiang G. Cancer Res; 2021 Dec 15; 81(24):6142-6156. PubMed ID: 34702726 [Abstract] [Full Text] [Related]
8. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y, Peng C, Chen J, Chen D, Yang B, He B, Hu W, Zhang Y, Liu H, Dai L, Xie H, Zhou L, Wu J, Zheng S. Mol Cancer; 2019 Aug 22; 18(1):127. PubMed ID: 31438961 [Abstract] [Full Text] [Related]
9. Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review). Issah MA, Wu D, Zhang F, Zheng W, Liu Y, Fu H, Zhou H, Chen R, Shen J. Int J Oncol; 2021 Dec 22; 59(6):. PubMed ID: 34792180 [Abstract] [Full Text] [Related]
10. Oxidative stress is two-sided in the treatment of acute myeloid leukemia. Fan C, Yang X, Yan L, Shi Z. Cancer Med; 2024 May 22; 13(9):e6806. PubMed ID: 38715546 [Abstract] [Full Text] [Related]
11. WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner. Chen S, Li Y, Zhi S, Ding Z, Wang W, Peng Y, Huang Y, Zheng R, Yu H, Wang J, Hu M, Miao J, Li J. Cell Death Dis; 2020 Aug 19; 11(8):659. PubMed ID: 32814762 [Abstract] [Full Text] [Related]
12. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells. Bista R, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, Aleem E. J Exp Clin Cancer Res; 2017 Feb 01; 36(1):22. PubMed ID: 28143565 [Abstract] [Full Text] [Related]
13. HIF1α-mediated transactivation of WTAP promotes AML cell proliferation via m6A-dependent stabilization of KDM4B mRNA. Shao YL, Li YQ, Li MY, Wang LL, Zhou HS, Liu DH, Yu L, Lin J, Gao XN. Leukemia; 2023 Jun 01; 37(6):1254-1267. PubMed ID: 37087529 [Abstract] [Full Text] [Related]
14. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z, Li Q, Liu P, Dong W, Zuo Y. Cell Biol Int; 2020 Dec 01; 44(12):2524-2531. PubMed ID: 32869897 [Abstract] [Full Text] [Related]
15. Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions. Wang X, Ma R, Zhang X, Cui L, Ding Y, Shi W, Guo C, Shi Y. Mol Cancer; 2021 Sep 24; 20(1):121. PubMed ID: 34560891 [Abstract] [Full Text] [Related]
16. Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase. Wang X, Gao M, Zhang J, Ma Y, Qu W, Liang J, Wu H, Wen H. Redox Biol; 2019 Jun 24; 24():101153. PubMed ID: 30909158 [Abstract] [Full Text] [Related]
17. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1. Hu C, Fu X, Li S, Chen C, Zhao X, Peng J. Daru; 2024 Jun 24; 32(1):11-24. PubMed ID: 37926762 [Abstract] [Full Text] [Related]
18. m6A mRNA Methylation Regulates LKB1 to Promote Autophagy of Hepatoblastoma Cells through Upregulated Phosphorylation of AMPK. Li G, Deng L, Huang N, Cui Z, Wu Q, Ma J, Pan Q, Sun F. Genes (Basel); 2021 Oct 30; 12(11):. PubMed ID: 34828353 [Abstract] [Full Text] [Related]
19. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C, Sheng Y, Wang Y, Wunderlich M, Zhang B, Dore LC, Su R, Deng X, Ferchen K, Li C, Sun M, Lu Z, Jiang X, Marcucci G, Mulloy JC, Yang J, Qian Z, Wei M, He C, Chen J. Cell Stem Cell; 2018 Feb 01; 22(2):191-205.e9. PubMed ID: 29290617 [Abstract] [Full Text] [Related]
20. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Nakamura S, Hirano I, Okinaka K, Takemura T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S, Ohnishi K. Carcinogenesis; 2010 Nov 01; 31(11):2012-21. PubMed ID: 20823107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]